Trial intelligence / Profile preview

EMLA for Diabetic Foot Sensibility

NCT00959595Phase 3Completed

Sponsor
Skåne University Hospital
Start
Nov 2008
Primary completion
Jan 2010
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of lidocaine + prilocaine in diabetic neuropathy, sponsored by Skåne University Hospital. Started Nov 2008; status: completed.

02

Drugs

lidocaine + prilocaine
03

Conditions

diabetic neuropathy

Beyond the preview

Go deeper on NCT00959595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00959595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call